Skip to main content
. 2018 Nov 22;24(1):92–96. doi: 10.1016/j.rpor.2018.10.009

Table 3.

Achieving the benchmark: the number of prostate cancer cases with overall scores similar or better than the delivered clinical plan (n = 77).

VMAT T5 compared to CP IMRT R5 compared to CP VMAT T5 compared to R5
Similar 4 (5.19%) 13 (16.88%) 10 (12.99%)
Better 51 (66.23%) 33 (42.86%) 48 (62.34%)
Similar or better 55 (71.43%) 46 (59.74%) 58 (75.32%)

Comparisons with CP: similar = ±1 metric point on overall score; better = > 1 metric point on overall score.